Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

756 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The 2019 American College of Rheumatology/European League Against Rheumatism Classification Criteria for IgG4-Related Disease.
Wallace ZS, Naden RP, Chari S, Choi H, Della-Torre E, Dicaire JF, Hart PA, Inoue D, Kawano M, Khosroshahi A, Kubota K, Lanzillotta M, Okazaki K, Perugino CA, Sharma A, Saeki T, Sekiguchi H, Schleinitz N, Stone JR, Takahashi N, Umehara H, Webster G, Zen Y, Stone JH; American College of Rheumatology/European League Against Rheumatism IgG4-Related Disease Classification Criteria Working Group. Wallace ZS, et al. Among authors: saeki t. Arthritis Rheumatol. 2020 Jan;72(1):7-19. doi: 10.1002/art.41120. Epub 2019 Dec 2. Arthritis Rheumatol. 2020. PMID: 31793250
[Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Research Program of Intractable Disease provided by the Ministry of Health, Labor, and Welfare of Japan].
Research Committee to establish diagnostic criteria and development of treatment for systemic IgG4-related sclerosing disease; Research Committee to establish a new clinical entity, IgG4-related multi-organ lymphoproliferative syndrome (IgG 4-MOLPS). Research Committee to establish diagnostic criteria and development of treatment for systemic IgG4-related sclerosing disease, et al. Nihon Naika Gakkai Zasshi. 2012 Mar 10;101(3):795-804. doi: 10.2169/naika.101.795. Nihon Naika Gakkai Zasshi. 2012. PMID: 22620057 Japanese. No abstract available.
IgG4-related disease in the Japanese population: a genome-wide association study.
Terao C, Ota M, Iwasaki T, Shiokawa M, Kawaguchi S, Kuriyama K, Kawaguchi T, Kodama Y, Yamaguchi I, Uchida K, Higasa K, Yamamoto M, Kubota K, Yazumi S, Hirano K, Masaki Y, Maguchi H, Origuchi T, Matsui S, Nakazawa T, Shiomi H, Kamisawa T, Hasebe O, Iwasaki E, Inui K, Tanaka Y, Ohshima KI, Akamizu T, Nakamura S, Nakamura S, Saeki T, Umehara H, Shimosegawa T, Mizuno N, Kawano M, Azumi A, Takahashi H, Mimori T, Kamatani Y, Okazaki K, Chiba T, Kawa S, Matsuda F; Japanese IgG4-Related Disease Working Consortium. Terao C, et al. Among authors: saeki t. Lancet Rheumatol. 2019 Sep;1(1):e14-e22. doi: 10.1016/S2665-9913(19)30006-2. Epub 2019 Aug 6. Lancet Rheumatol. 2019. PMID: 38229354
Improved Renal Function in Initial Treatment Improves Patient Survival, Renal Outcomes, and Glucocorticoid-Related Complications in IgG4-Related Kidney Disease in Japan.
Mizushima I, Saeki T, Kobayashi D, Sawa N, Hayashi H, Taniguchi Y, Nakata H, Yamada K, Matsui S, Yasuno T, Masutani K, Nagasawa T, Takahashi H, Ubara Y, Yanagita M, Kawano M. Mizushima I, et al. Among authors: saeki t. Kidney Int Rep. 2023 Oct 20;9(1):52-63. doi: 10.1016/j.ekir.2023.10.016. eCollection 2024 Jan. Kidney Int Rep. 2023. PMID: 38312790 Free PMC article.
Validation of the Diagnostic Criteria for IgG4-Related Periaortitis/Periarteritis and Retroperitoneal Fibrosis (IgG4PA/RPF) 2018, and Proposal of a Revised 2023 Version for IgG4-Related Cardiovascular/Retroperitoneal Disease.
Mizushima I, Morikage N, Ito E, Kasashima F, Matsumoto Y, Sawa N, Yoshifuji H, Saeki T, Shintani-Domoto Y, Shimada S, Takayama T, Amiya E, Ozawa M, Takahashi M, Fujinaga Y, Katsumata T, Obitsu Y, Izawa A, Kanno H, Oyama-Manabe N, Ishizaka N, Nagasawa T, Takahashi H, Ohki T, Kawano M, Kasashima S; Joint Working Group from the Japanese Circulation Society and the Ministry of Health, Labour and Welfare Study Group. Mizushima I, et al. Among authors: saeki t. Circ J. 2024 Sep 25;88(10):1679-1688. doi: 10.1253/circj.CJ-24-0026. Epub 2024 Mar 16. Circ J. 2024. PMID: 38494710 Free article.
Clinical profile of IgG4-related disease in Japan based on the rare disease data registry.
Yamamoto M, Kanda M, Mizushima I, Kanno A, Umemura T, Ikeura T, Kodama Y, Dobashi H, Tanaka Y, Masamune A, Moriyama M, Saeki T, Matsui S, Origuchi T, Masaki Y, Asada M, Umehara H, Seno H, Naitoh I, Yamamoto S, Iwasaki E, Kubota K, Tanoue S, Nishino T, Tsuboi H, Matsumoto Y, Isayama H, Goto H, Notohara K, Uchida K, Kawabe K, Yamada K, Kasashima S, Takahira M, Sato Y, Kawachi I, Yamaguchi I, Okazaki K, Nakamura S, Matsuda F, Ishikawa H, Kawano M; Patient Registry Committee, Research Program for Intractable Disease by the Ministry of Health, Labour and Welfare (MHLW), Japan; *Other than the co-authors, the members of Patient Registry Committee, Research Program for Intractable Disease by the Ministry of Health, Labour and Welfare (MHLW), Japan are as follows: Kensuke Yokoyama (Jichi Medical University);. Yamamoto M, et al. Among authors: saeki t. Immunol Med. 2024 Nov 28:1-11. doi: 10.1080/25785826.2024.2430812. Online ahead of print. Immunol Med. 2024. PMID: 39607031 Free article.
Characteristic tubulointerstitial nephritis in IgG4-related disease.
Yamaguchi Y, Kanetsuna Y, Honda K, Yamanaka N, Kawano M, Nagata M; Japanese study group on IgG4-related nephropathy. Yamaguchi Y, et al. Hum Pathol. 2012 Apr;43(4):536-49. doi: 10.1016/j.humpath.2011.06.002. Epub 2011 Sep 1. Hum Pathol. 2012. PMID: 21889187
756 results